HRT Financial’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

HRT Financial’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,212	Closed	–	–	3392
2023 Q2	$0	Hold	10,212	–	–	﹤0.01%	3582
2023 Q1	$0	Hold	10,212	–	–	﹤0.01%	3453
2022 Q4	$0	Sell	10,212 -2,432	-19%	-$195	﹤0.01%	3477
2022 Q3	$2K	Buy	12,644 +2,432	+24%	+$600	﹤0.01%	2663
2022 Q2	$1K	Buy	+10,212	New	+$1.69K	﹤0.01%	2826

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

HRT Financial's APGNW Position: Q3 2023 in Review

HRT Financial sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 10,212 shares.

HRT Financial first reported a position in APGNW in Q2 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

HRT Financial reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 10,212 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023.
HRT Financial first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q2 2022 and held it in 5 quarters.
HRT Financial's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $2K in Q3 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.